| Serial Number | 97792209 |
| Word Mark | HELIX BIOTECH |
| Filing Date | Monday, February 13, 2023 |
| Status | 654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED |
| Status Date | Tuesday, February 18, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of the stylized wording "HELIX BIOTECH" and design. The letter "X" in "HELIX" is formed by a stylized DNA helix symbol. The term "HELIX" appears in a large font above the term "BIOTECH" which is centered below and appears in a small font. |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | BIOTECH |
| Goods and Services | Chemical analysis; Chemical analysis services; Chemical research and analysis; Chemical, biochemical, biological and bacteriological research and analysis; Clinical research in the field of Lipid Nanoparticles, Liposomes, and Hybrid Nanoparticles; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Product development; Product development and engineering services for others; Product development consultation; Product development consulting in the field of Lipid Nanoparticles (LNPs) and Liposome Samples. LNP and Liposome Formulation, Manufacturing, and Analytical Services; Product development for others; Product research and development; Basic and clinical research in the field of respiratory science and medicine; Consulting services for others in the field of design, planning, and implementation project management of Lipid Nanoparticles, Liposomes, and Hybrid Nanoparticles; Consulting services in the field of product design and development; Design and testing for new product development; Executing of chemical analyses; Medical and scientific research, namely, conducting clinical trials for others; Performance of chemical analyses; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Providing a website featuring educational information in the field of clinical research; Providing information on clinical studies via an interactive website; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Scientific research in the nature of conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others in the field of Lipid Nanoparticles, Liposomes, and Hybrid Nanoparticles; Testing, analysis and evaluation of leaf and petiole samples; Working on and evaluation of chemical analyses |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 2, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Helix Biotech, Inc |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Knoxville, TN 37918 |
| Event Date | Event Description |
| Thursday, February 16, 2023 | NEW APPLICATION ENTERED |
| Thursday, March 2, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, January 8, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, March 3, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, November 10, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, November 15, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, November 15, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, November 15, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, February 12, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, February 12, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, January 8, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, January 8, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, February 12, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, April 15, 2024 | LETTER OF SUSPENSION E-MAILED |
| Monday, April 15, 2024 | SUSPENSION LETTER WRITTEN |
| Monday, April 15, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, January 24, 2025 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Tuesday, February 18, 2025 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |